
|Articles|February 5, 2017
Drug Approvals Take 2017 By Storm Highlights AJPB Week in Review
Author(s)Laurie Toich, Assistant Editor
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Phase 3 MonumenTAL-3 Trial Demonstrates Significant Survival Benefit With Talquetamab-Based Regimens in Relapsed/Refractory Multiple Myeloma
2
Metformin Cuts Long COVID Risk by 50%, New Trial Confirms
3
FDA Approves Capvaxive Expanded Indication to Include Children, Adolescents at Increased Risk for Pneumococcal Disease
4
FDA Clears First Single-Inhaler Triple Therapy for Asthma
5


















































































































